high
throughput
screen
increas
accuraci
coupl
realtim
quantit
pcr
qpcr
robot
setup
system
begin
revolutionis
biotechnolog
applic
qpcr
within
biotechnolog
discuss
particular
emphasi
follow
area
biosafeti
genet
stabil
test
determin
biodistribut
gene
therapi
vector
anim
b
quantif
residu
dna
final
product
therapeut
c
detect
viral
bacteri
nucleic
acid
contamin
cell
bank
final
product
quantif
level
viru
remov
process
valid
viral
clearanc
studi
e
specif
detect
retrovir
rt
activ
vaccin
high
sensit
f
transgen
copi
number
determin
monitor
genet
stabil
product
method
employ
qpcr
assay
valid
requir
ich
topic
valid
analyt
method
definit
terminolog
june
also
review
realtim
quantit
polymeras
chain
tion
qpcr
revolutionis
detect
quantif
nucleic
acid
retrovir
revers
transcriptas
fast
throughput
capabl
morri
et
al
lovatt
et
al
nitsch
et
al
incorpor
bulk
harvest
materi
amplif
targetspecif
oligonucleotid
primer
fluorogen
oligonucleotid
probe
report
dye
fam
vic
tet
joe
hex
quencher
dye
tamra
attach
anneal
specif
amplifi
product
amplim
detect
reaction
utilis
exonucleas
activ
amplitaq
gold
tm
dna
polymeras
cleav
report
dye
probe
result
increas
fluoresc
target
present
fig
sequenc
detector
instrument
calcul
report
dye
valu
r
sampl
cycl
amplin
ficat
valu
r
normalis
ren
porter
signal
repres
fluoresc
report
dye
divid
passiv
refer
dye
pcr
r
increas
amplicon
copi
n
number
increas
reaction
approach
plateau
valu
r
repres
norn
malis
report
signal
r
minu
baselin
n
signal
establish
first
cycl
pcr
like
r
r
increas
pcr
amn
n
plicon
copi
number
increas
reaction
reach
plateau
fig
use
sequenc
detector
allow
measur
amplifi
product
direct
proport
increas
fluoresc
emiss
continu
pcr
amplif
threshold
cycl
c
valu
calcul
real
time
defin
pcr
cycl
number
increas
report
fluoresc
baselin
signal
first
detect
therefor
cycl
point
given
amplif
signific
increas
fluoresc
signal
associ
exponenti
growth
pcr
product
first
detect
resent
c
valu
amplif
fig
linear
relationship
exist
c
valu
start
quantiti
target
molecul
allow
construct
standard
curv
greater
amount
target
copi
reaction
lower
c
valu
fig
heid
et
al
livak
perkin
elmer
mani
advantag
real
time
qpcr
convent
endpoint
pcr
exampl
realtim
qpcr
perform
close
reaction
system
elimin
postpcr
process
pcr
product
therebi
increas
throughput
reduc
chanc
carryov
contamin
moreov
taqman
qpcr
system
incorpor
chemic
system
term
amperas
avoid
amplicon
contamin
like
convent
qualit
pcr
assay
qpcr
assay
oper
strict
contamin
control
system
ie
separ
air
space
reaction
give
increas
assur
reavoid
crosscontamin
increas
throughput
real
time
qpcr
higher
assay
sensit
achiev
rel
eas
multipl
replic
reaction
use
increas
chanc
observ
low
level
viru
limit
detect
heid
et
al
livak
perkin
elmer
addit
coupl
realtim
qpcr
robot
extract
pcr
setup
system
increas
throughput
minimis
human
error
c
valu
also
less
sensit
endpoint
reaction
effect
inhibitor
compar
endpoint
pcr
real
time
qpcr
offer
streamlin
assay
develop
reproduc
result
larg
dynam
rang
importantli
sampl
contain
viral
sequenc
amount
target
nucleic
acid
molecul
present
given
provid
indic
level
viral
contamin
present
could
use
decid
action
take
exampl
pcrposit
sampl
bulk
harvest
materi
process
valid
could
use
determin
sampl
still
gave
tive
result
heid
et
al
livak
perkin
elmer
primer
design
realtim
taqman
pcr
perform
use
primer
express
tm
softwar
abi
follow
pe
appli
biosystem
recommend
one
first
step
identif
nucleic
acid
target
comparison
target
sequenc
amplicon
use
multipl
sequenc
align
dna
sequenc
databank
allow
assess
potenti
crossreact
relat
sequenc
may
produc
problem
qpcr
test
determin
primer
specif
utmost
import
perform
pathogen
detect
studi
fals
posit
reaction
although
uncommon
lead
major
problem
releas
biotechnolog
product
clinic
trial
therefor
assay
specif
studi
critic
valid
ensur
confid
report
posit
result
qpcr
assay
abl
discrimin
target
nucleic
acid
like
present
test
materi
detect
virus
human
munodefici
viru
hiv
virus
show
sequenc
variat
extrem
import
ensur
primer
probe
target
conserv
region
viral
genom
select
region
highli
conserv
sequenc
facilit
design
degener
amplim
probe
allow
detect
maximum
amount
variant
strain
possibl
shown
fig
bovinerporcin
circoviru
addit
stabil
target
sequenc
consid
attempt
ensur
amplicon
resid
unstabl
genet
element
may
hot
spot
delet
occur
polyoma
viru
bendig
folk
pers
ensur
technic
reliabl
assay
optimis
studi
essenti
togeth
valid
ich
guidelin
ich
topic
ich
topic
cope
minimum
two
oper
perform
specif
linear
detect
limit
accuraci
repeat
studi
oper
determin
assay
paramet
least
use
minimum
five
concentr
rang
assay
import
optimis
valid
highlight
work
nonvalid
rapidli
develop
qpcr
assay
high
background
fluoresc
signal
lead
reduc
assay
sensit
abnorm
amplif
signal
observ
assay
assay
optimis
valid
support
need
assay
valid
importantli
less
experienc
oper
may
abl
distinguish
genuin
abnorm
amplif
signal
test
nonoptimis
nonvalid
assay
primer
optimis
carri
use
array
primer
concentr
constant
amount
probe
target
templat
high
r
valu
reflect
increas
level
amplin
ficat
product
effici
reaction
combin
forward
revers
primer
show
maximum
r
select
probe
optimisan
tion
perform
use
optimis
primer
con
dition
wherebi
concentr
probe
vari
probe
concentr
show
lowest
c
valu
chosen
optim
reflect
effici
reaction
condit
assay
linear
detect
limit
precis
assess
use
eight
replic
reaction
rang
five
concentr
assess
ducibl
correl
coeffici
r
yintercept
slope
regress
line
calcul
use
minimum
two
independ
oper
abi
system
minimum
accept
valu
linear
correl
coeffici
ps
statist
level
use
four
standard
wardlaw
qpcr
assay
normal
show
valu
r
two
major
complic
factor
establish
detect
limit
realtim
pcr
assay
use
biolog
materi
number
target
nucleic
molecul
present
infect
cell
clinic
sampl
electron
microscopi
count
viral
stock
may
variabl
may
cultur
method
avail
target
organ
therefor
limit
detect
firstli
valid
use
purifi
target
molecul
form
recombin
plasmid
dna
recombin
rna
assay
limit
detect
confid
defin
lowest
amount
target
produc
confid
interv
significantli
lower
obtain
eight
neg
control
templat
control
within
group
eight
replic
contain
target
level
limit
detect
fail
reaction
replic
produc
amplif
signal
c
valu
less
assay
limit
detect
routin
determin
nucleic
acid
copi
background
cellular
genom
dna
target
ng
cellular
rna
rna
target
ultim
assess
assay
reproduc
requir
posit
cutoff
point
determin
posit
cutoff
level
minimum
number
target
molecul
detect
test
run
posit
cutoff
point
assay
measur
period
month
use
differ
batch
reagent
sever
differ
oper
extract
viral
nucleic
acid
wide
use
diagnost
research
laboratori
howev
suitabl
yield
nucleic
acid
extract
procedur
vari
depend
nucleic
acid
biolog
materi
kok
et
al
therefor
ensur
effici
extract
target
nucleic
acid
procedur
qualifi
particular
target
biolog
materi
use
sinc
qpcr
allow
quantif
nucleic
acid
target
molecul
use
determin
percentag
recoveri
viral
cellular
dna
target
achiev
extract
procedur
tabl
assess
perform
extract
procedur
extract
test
nucleic
acid
spike
target
molecul
determin
percentag
pcr
inhibit
calcul
copi
number
test
sampl
subsequ
adjust
take
account
amount
lost
extract
estim
level
inhibit
pcr
inhibit
particularli
import
assess
analys
mani
differ
biolog
materi
may
contain
variou
level
inhibitori
substanc
extract
nucleic
acid
cell
free
sampl
especi
final
product
import
includ
carrier
molecul
procedur
allow
maximum
recoveri
low
level
nucleic
acid
critic
ensur
maximum
sensit
pcr
assay
essenti
screen
vaccin
contamin
host
cell
dna
determin
qpcr
typic
extract
recoveri
greater
achiev
pg
human
cell
line
dna
per
therapeut
dose
use
qiagen
dna
mini
kit
tabl
similar
result
obtain
use
qpcr
assay
primat
rodent
chicken
porcin
cellular
dna
inhibitori
factor
interfer
pcr
appar
perform
extract
viral
plasmid
nucleic
acid
anim
tissu
secret
substanc
heparin
urea
haemoglobin
ethanol
isopropanol
inhibit
pcr
affect
extract
effici
qiagen
use
method
remov
molecul
utmost
import
screen
tissu
gene
cell
therapi
biodistribut
studi
therefor
studi
use
optimis
high
throughput
nucleic
acid
extract
system
examin
recoveri
copi
target
nucleic
acid
highest
amount
tissu
possibl
determin
recoveri
percentag
valu
plasmid
dna
per
g
anim
tissu
shown
tabl
cycl
complet
data
analys
real
time
c
valu
replic
observ
record
standard
deviat
confid
limit
c
valu
replit
cate
calcul
detect
similar
signific
differ
group
replic
firstli
imposs
posit
result
may
deriv
nucleic
acid
previous
unrecognis
origin
show
nonspecif
interact
due
sequenc
homolog
amplif
target
use
detect
valid
assay
posit
result
test
sampl
consid
occur
follow
four
condit
met
test
sampl
two
independ
amplim
set
specifi
target
signific
amplif
signal
sent
test
sampl
reaction
amplif
signal
present
sentinel
trol
amplif
signal
sent
neg
control
signific
amplif
signal
present
test
articl
spike
limit
detect
detect
target
sequenc
pcr
sentinel
neg
control
invalid
assay
indic
contamin
posit
test
confid
analysi
data
result
c
valu
test
sampl
spike
test
sampl
posit
control
sampl
significantli
less
negativersentinel
reaction
level
target
molecul
limit
detect
posit
reaction
occur
one
three
two
three
replic
neg
replic
produc
c
confid
interv
test
sampl
significantli
differ
neg
control
reaction
case
confid
interv
contain
posit
amplif
signal
test
sampl
reaction
produc
overlap
neg
control
result
could
therefor
consid
equivoc
signal
detect
valid
assay
sensit
increas
sampl
volum
analys
appropri
test
carri
independ
procedur
cell
infect
qpcr
end
point
analysi
valid
assay
neg
result
test
sampl
consid
occur
follow
four
condit
met
test
sampl
amplif
signal
present
test
sampl
reaction
amplif
signal
present
sentinel
control
amplif
signal
present
neg
control
amplif
signal
detect
spike
posit
control
reaction
neg
test
confid
analysi
data
result
c
valu
sentinel
control
neg
control
test
articl
significantli
greater
test
articl
spike
limit
detect
occasion
one
three
two
three
replic
test
sampl
spike
limit
detect
may
contain
c
amplificat
tion
detect
test
articl
confid
interv
show
spike
data
significantli
differ
test
articl
neg
control
data
case
result
would
consid
neg
confid
sinc
test
abl
detect
amplif
signal
spike
replic
accuraci
quantit
data
number
qpcr
assay
determin
use
minimum
eight
replic
contain
ident
amount
dna
viral
rna
spread
across
rang
concentr
analysi
four
replic
term
standard
four
replic
design
unknown
gener
standard
curv
quantif
unknown
accuraci
quantit
softwar
combin
assess
qpcr
assay
determin
result
show
qpcr
assay
abl
quantifi
accur
correct
amount
within
one
standard
deviat
dna
rna
target
tabl
detail
valu
x
standard
curv
actual
amount
enteroviru
rna
standard
correspond
calcul
valu
w
mean
standard
devia
tion
amount
calcul
unknown
replic
contain
ident
amount
nucleic
acid
x
standard
sensit
abi
twoto
fourfold
copi
number
differ
mean
valu
vari
fourfold
could
calcul
differ
actual
valu
work
twoto
fourfold
copi
number
differ
level
therefor
actual
valu
x
copi
accept
criteria
could
oneto
twofold
variat
either
side
copi
eg
copi
total
twoto
fourfold
variat
actual
valu
x
therefor
valu
would
within
accept
criteria
valu
outsid
accept
limit
could
consid
highli
variabl
accur
quantif
approach
may
allow
one
actual
valu
x
known
amount
standard
reaction
valu
amount
calcul
standardis
unknown
gener
standard
curv
express
mean
copi
number
sd
assess
perform
standard
overal
qpcr
assay
term
quantif
accuraci
adventiti
agent
pose
signific
risk
present
vaccin
therapeut
therefor
highli
sensit
pcr
assay
detect
agent
crucial
safeti
test
numer
viral
nucleic
acid
detect
assay
avail
avail
number
fulli
valid
qpcr
pathogen
detect
assay
increas
consider
rate
besid
viralspecif
nucleic
acid
detect
one
import
use
qpcr
technolog
safeti
test
detect
contamin
retrovirus
identif
presenc
retrovir
revers
transcriptas
activ
lovatt
et
al
fluoresc
product
enhanc
revers
scriptas
fpert
assay
extrem
sensit
test
detect
revers
tase
rt
fpert
fold
sensit
convent
rt
assay
detect
presenc
retrovirus
maudru
peden
lovatt
et
al
increas
sensit
prompt
center
biolog
tion
research
cber
request
pert
test
viral
vaccin
investig
human
consequ
fpert
first
choic
detect
rt
live
viral
vaccin
gene
therapi
prepar
screen
anim
patient
porcin
endogen
viru
perv
xenotransplant
trial
fpert
rtdepend
qpcr
assay
therefor
combin
broad
specif
convent
rt
assay
high
sensit
fast
throughput
qpcr
convent
rt
assay
fpert
utilis
detect
rt
activ
packag
extracellular
retroviru
particl
assay
involv
convert
rna
templat
cdna
amplifi
cdna
use
productspecif
primer
exogen
rt
activ
ad
reaction
cdna
gener
sampl
contain
rt
activ
rt
activ
present
product
detect
silver
et
al
pyra
et
al
henein
et
al
arnold
et
al
one
major
advantag
fpert
assay
similar
type
assay
capabl
discrimin
amplif
signal
gener
retrovir
rt
activ
result
rtlike
activ
dna
polymeras
fpert
use
activ
calf
thymu
dna
suppress
rtlike
activ
cellular
taq
dna
polymeras
reduct
rt
activ
tabl
linear
relationship
threshold
cycl
c
number
mlv
retroviru
particl
rt
perv
approxim
virion
particl
molecul
purifi
amv
rt
enzym
howev
assay
detect
lower
level
retroviru
decreas
frequenc
overview
fpert
assay
describ
flow
diagram
fig
high
sensit
fpert
ensur
qpcr
assay
play
signific
role
evalu
retrovir
statu
vaccin
biolog
materi
biotechnolog
industri
safeti
product
paramount
specif
perform
combin
cocultiv
induct
infect
assay
togeth
electron
microscopi
em
pathogenspecif
pcr
detect
assay
fpert
assist
provid
detail
risk
assess
presenc
adventiti
agent
therapeut
virus
may
contamin
cell
line
number
sourc
includ
present
virus
anim
origin
media
tissu
cultur
reagent
oper
sourc
could
contamin
cell
handl
nongmp
condit
reason
cell
line
primari
cell
tissu
product
use
therapeut
purpos
requir
test
presenc
rang
virus
select
virus
test
depend
upon
origin
cell
line
raw
materi
use
manufactur
develop
valid
pcr
assay
meet
requir
regulatori
author
key
element
product
market
final
product
increas
number
publish
valid
qpcr
assay
becom
avail
test
utilis
cell
line
raw
materi
final
product
test
tabl
test
presenc
human
virus
requir
cell
human
origin
product
obtain
human
blood
tissu
involv
exampl
includ
hybridoma
cell
line
human
origin
use
product
adenoviru
vector
therapi
broad
term
virus
screen
human
cell
line
associ
sever
oncogen
diseas
like
infect
cell
type
particularli
might
establish
latent
abort
replic
cell
anim
virus
pose
signific
risk
cell
line
therapeut
anim
origin
andror
anim
product
foetal
calf
serum
trypsin
insulin
use
manufactur
cultur
new
anim
reagent
use
manufactur
screen
appropri
techniqu
bovin
serum
porcin
trypsin
usual
screen
use
appropri
titl
code
feder
regul
assay
howev
caution
requir
assay
use
minim
volum
may
miss
critic
virus
addit
virus
detect
assay
therefor
pcr
employ
mani
virus
concern
manufactur
process
subject
review
instead
section
focus
exampl
virus
recent
emerg
agent
concern
name
bovin
polyomaviru
bunyaviru
porcin
circoviru
recent
concern
express
contamin
bovin
product
bovin
polyomaviru
bpyv
viru
belong
famili
oncogen
host
heterolog
host
infect
cattl
widespread
foetal
calf
serum
batch
contain
bpyv
sequenc
pcr
infecti
viru
isol
batch
schuurman
et
al
worri
featur
viru
probabl
zoonot
replic
primat
cell
antibodi
viru
lack
gener
popul
veterinarian
cattl
farmer
abattoir
worker
seroposit
parri
gardner
detect
bpyv
quantit
pcr
fulli
valid
ich
guidelin
assay
capabl
detect
viral
genom
copi
routin
basi
bunyavirida
famili
contain
virus
group
five
genera
unlik
envelop
virus
bud
intracytoplasm
vesicl
associ
golgi
apparatu
form
virion
nm
diamet
genom
viru
segment
three
strand
permit
complex
reassort
occur
influenza
viru
consequ
taxonomi
virus
complex
borucki
et
al
mahi
within
bunyaviru
genu
relev
serogroup
genet
complex
californian
serogroup
bunyamwera
serogroup
within
bunyamwera
group
cach
valley
viru
cvv
recognis
infect
sheep
cattl
cvv
transmit
congenit
infect
foetal
calf
serum
possibl
mclean
et
al
blackmor
grimstad
edward
et
al
chung
et
al
emphasis
cvv
potenti
problemat
larg
scale
ferment
cultur
manufactur
cvv
lytic
cell
line
includ
vero
therefor
also
detect
culturebas
bioassay
edward
et
al
sinc
cvv
suspect
caus
foetal
malform
cattl
presenc
viru
serum
repres
major
safeti
concern
edward
et
al
detect
cvv
quantit
rtpcr
fulli
valid
ich
guidelin
assay
capabl
detect
viral
rna
copi
routin
basi
confid
interv
c
valu
produc
viral
copi
per
ng
noninfect
cellular
rna
significantli
differ
neg
control
rna
use
two
oper
circovirus
amongst
smallest
mammalian
virus
approxim
nm
like
parvovirus
highli
resist
environ
q
ment
porcin
circoviru
type
nucleotid
sequenc
homolog
bovin
coviru
bcv
shown
involv
format
organ
lesion
pig
close
relationship
two
virus
led
suggest
group
virus
may
cross
speci
barrier
case
circovirus
remain
latent
persist
noncytopath
infect
vitro
allan
elli
techniqu
current
avail
detect
form
circoviru
limit
current
test
differenti
infecti
viru
nucleic
acid
consequ
specif
qpcr
assay
requir
detect
virus
shown
fig
multipl
sequenc
align
bovin
circoviru
porcin
circoviru
genom
identifi
qpcr
primer
probe
detect
rang
strain
isol
mani
global
locat
bovin
circoviru
porcin
circoviru
qpcr
fulli
valid
ich
guidelin
routin
detect
genom
copi
summari
cvv
bpyv
porcin
circoviru
bovin
circoviru
repres
new
threat
biotechnolog
product
step
need
incorpor
monitor
virus
appropri
subpool
test
foetal
calf
serum
test
raw
materi
conduct
sinc
possibl
effect
cell
viabil
may
note
appropri
bulk
harvest
screen
cultur
undertaken
exclud
presenc
virus
therebi
avoid
expens
contamin
downstream
purif
train
process
valid
studi
usual
perform
use
downscal
manufactur
purif
process
allow
assess
capac
effici
process
remov
inactiv
virus
dna
contamin
manufactur
produc
recombin
protein
rodent
cell
line
eg
hybridoma
cho
requir
perform
murin
leukemia
viru
clearanc
studi
phase
irii
clinic
trial
gener
process
phase
iii
studi
requir
clearanc
three
virus
demonstr
feder
regist
feder
guidelin
specifi
infect
use
technic
feasibl
altern
technolog
may
justifi
howev
increas
number
manufactur
use
infect
qpcr
demonstr
viral
remov
murin
leukemia
virus
endogen
provirus
divid
two
main
group
ecotrop
nonecotrop
virus
ecotrop
virus
infect
mous
cell
nonecotrop
virus
subdivid
three
group
xenotrop
polytrop
modifi
polytrop
xenotrop
mlv
infect
human
cell
natur
rodent
host
cell
polytrop
mlv
also
term
minkcel
focu
mcf
form
mlv
infect
rodent
nonrod
cell
broader
host
rang
xenotrop
mlv
unlik
xenotrop
ecotrop
mlv
infecti
polytrop
mlv
preexist
mous
germ
line
aris
recombin
infecti
ecotrop
mlv
endogen
mlvrelat
polytrop
sequenc
certain
laboratori
mous
strain
progeni
sever
nonecotrop
mlv
recombin
exogen
endogen
mlv
sequenc
result
oncogen
variant
mcf
viru
tomonaga
coffin
provir
xenotrop
mlv
capabl
produc
infecti
viru
present
inbr
mice
popul
balbc
endogen
xenotrop
mlv
term
appear
ltr
donor
leukemogen
mcf
form
mlv
addit
xenotrop
mlv
deriv
locu
first
describ
balbrc
mice
infecti
kozak
ruscetti
murin
hybridoma
cell
use
pharmaceut
monocolon
antibodi
product
express
xenotrop
mlv
regulatori
agenc
recommend
retroviru
inactiv
remov
manufactur
addit
mlv
use
model
viru
evalu
elimin
noninfecti
cho
cell
retroviru
particl
retrovir
clearanc
studi
use
viru
inactiv
treatment
low
ph
elut
buffer
manufactur
viral
clearanc
studi
scale
condit
involv
spike
load
sampl
known
amount
infecti
viru
allow
assess
retrovir
remov
examin
eluat
infect
assay
qpcr
howev
buffer
inactiv
viru
use
chromatographi
process
reduct
infecti
viru
titr
eluat
due
combin
result
matographi
remov
buffer
inactiv
lau
et
al
case
infect
assay
provid
clearanc
inform
wherea
qpcr
resolv
problem
initi
essenti
qualifi
viral
clearanc
qpcr
assay
use
quantit
result
spike
load
unspik
load
control
cell
line
murin
hybrodoma
ensur
absenc
nonspecif
interact
obscur
clearanc
data
retrovir
nucleic
acid
clearanc
essenti
perform
dna
rna
copi
number
quantif
viral
spike
spike
column
elut
analysi
xmlv
nucleic
acid
copi
number
absenc
rt
enzym
allow
estim
percentag
provir
dna
target
result
background
residu
host
cell
dna
viral
product
cell
line
recalcul
rna
copi
number
ensur
detect
viral
rna
genom
achiev
result
take
account
background
integr
proviru
present
residu
product
cell
genom
dna
differ
two
rna
copi
number
obtain
viral
spike
spike
column
elut
allow
calcul
viral
remov
fig
column
elut
sampl
alreadi
contain
xenotrop
mlv
rna
extract
differ
viru
spike
intern
extractionramplif
control
order
distinguish
mlv
alreadi
present
intern
control
spike
crossreact
actual
xenotrop
mlv
simplifi
calcul
unrel
rna
viru
known
tcid
nake
viral
rna
use
control
pcrrextract
interfer
viral
recoveri
extract
viral
remov
obtain
calcul
mean
rna
copi
number
load
hold
control
eluat
column
run
addit
xmlv
quantif
qpcr
assay
measur
clearanc
endogen
retroviru
chines
hamster
ovari
cho
cell
avail
shi
et
al
b
de
wit
et
al
taken
togeth
approach
allow
manufactur
clearanc
process
assess
abil
remov
log
viral
genom
therebi
pave
way
optimis
procedur
gener
maximum
viral
clearanc
manufactur
biopharmaceut
must
ensur
final
product
produc
start
cell
substrat
contain
minimum
level
residu
host
cell
dna
current
regulatori
guidelin
establish
fda
recommend
product
manufactur
continu
cell
line
contain
less
pg
cellular
dna
per
dose
lewi
et
al
danger
residu
dna
includ
malign
transform
activ
cellular
andror
viral
oncogen
aberr
gene
express
insert
sequenc
sensit
control
region
gene
well
product
infecti
virus
viral
dna
respons
concern
number
qpcr
assay
design
detect
quantifi
residu
dna
tabl
quantif
limit
residu
dna
qpcr
assay
usual
within
pg
per
reaction
pg
slotblot
techniqu
use
pradiolabel
probe
ge
nomic
dna
hybridis
autoradiographi
genom
equival
per
ml
sensit
expect
use
target
beta
actin
gene
target
sensit
sometim
increas
target
higher
copi
number
use
exampl
sequenc
repeat
region
within
genom
develop
qpcr
assay
repeat
region
rodent
primat
residu
dna
obtain
sensit
fg
rang
howev
one
advantag
use
gene
gene
stabil
target
undergo
copi
number
chang
within
stabl
cell
line
repeat
quenc
known
less
stabl
lewi
et
al
lobachev
et
al
may
undergo
signific
chang
copi
number
genom
therefor
potenti
obscur
residu
dna
data
shift
target
copi
number
occur
product
reason
choic
pcr
target
import
use
repeat
region
may
necessari
sensit
pg
level
requir
besid
qualif
final
product
batch
releas
residu
dna
assay
use
demonstr
clearanc
host
cell
dna
process
valid
addit
sinc
test
sampl
like
contain
detect
level
residu
dna
anoth
appropri
intern
control
dna
unrel
host
cell
test
sampl
spike
sampl
recoveri
intern
control
quantifi
use
pcr
reaction
specif
unrel
target
dna
import
intern
control
target
test
sampl
target
crossreact
term
sequenc
specif
simplifi
dna
recoveri
calcul
individu
test
sampl
qpcr
residu
dna
far
robust
convent
hybridis
method
exampl
qpcr
precis
larger
dyman
rang
convent
hybridis
method
smith
et
al
problem
standard
curv
encount
perform
linear
regress
convent
hybridis
autoradiographi
due
fact
xray
film
threshold
respons
sensit
result
nonlinear
respons
hybridis
signal
cornett
et
al
qpcr
hand
combin
highli
linear
respons
coupl
sensit
compar
hybridis
assay
addit
turnaround
time
qpcr
techniqu
rapid
less
labour
intens
autom
robot
system
remov
oper
error
sampl
manipul
qpcr
still
estim
amount
dna
benzonas
treat
product
exampl
dna
shear
size
bp
qpcr
essenti
determin
efficaci
gene
cell
therapeut
moreov
biodistribut
analysi
novel
therapeut
critic
assess
biosafeti
meet
increasingli
stringent
regulatori
guidelin
way
regulatori
issu
concern
infect
transfer
gene
normal
distal
tissu
well
target
site
address
addit
investig
possibl
integr
express
germ
line
perform
possibl
whole
organ
homogenis
aliquot
extract
remain
homogen
archiv
analysi
homogenis
whole
organ
give
insur
patch
localis
infect
organ
detect
therapeut
viral
cellular
base
detect
viral
cellular
rna
express
tissu
concern
may
indic
viru
cellular
replic
tissu
therefor
assay
target
condit
control
use
biodistribut
studi
critic
gener
highest
qualiti
data
satisfi
regulatori
author
prestudi
import
assess
best
condit
appli
overal
biodistribut
assay
problem
occur
biodistribut
studi
depend
complex
studi
design
prestudi
wide
variabl
depend
complex
therapeut
vector
howev
simplist
term
prestudi
use
demonstr
optim
pcr
nucleic
acid
extract
maximum
assay
sensit
address
high
qualiti
data
may
also
necessari
prepar
inactiv
vector
provid
materi
administr
neg
control
anim
help
control
presenc
residu
vector
nucleic
acid
becom
lodg
anim
organ
therefor
provid
inform
distinguish
signal
gener
replic
vector
residu
nucleic
acid
addit
vector
dna
viru
use
qrtpcr
incorpor
dnase
extract
minu
rt
reaction
control
help
distinguish
viral
express
residu
dna
anim
tissu
method
inactiv
viral
vector
depend
viru
may
either
uv
bpropriolacton
treatment
inactiv
prepar
verifi
amplif
use
cell
cultur
replic
viru
vector
examin
appropri
detect
method
exampl
cytopath
effect
qpcr
healthi
cell
treat
inactiv
vector
pass
sever
time
dilut
residu
inactiv
target
cultur
sampl
cell
taken
passag
time
point
quantifi
qpcr
without
rt
enzym
demonstr
reduct
residu
viral
nucleic
acid
absenc
low
level
infect
detect
limit
linear
reproduc
determin
assay
develop
valid
reaction
condit
optim
spike
neg
control
organ
analys
determin
lowest
amount
target
detect
maximum
amount
test
sampl
tissu
optim
extract
condit
appli
biodistribut
studi
anim
speci
use
biodistribut
studi
extrem
import
speci
must
accept
regulatori
author
use
safeti
evalu
studi
extens
background
data
avail
chosen
anim
speci
suscept
infect
rout
administr
intend
human
rout
vector
howev
intraven
rout
allow
better
assess
vector
biodistribut
anim
sex
use
studi
administr
dose
calcul
use
maximum
human
dose
base
equival
unit
per
kilogram
bodi
weight
exampl
anim
studi
design
examin
vector
biodistribut
could
low
group
high
dose
human
maxi
mum
group
b
low
dose
human
dose
group
c
high
dose
inactiv
group
contain
three
femal
three
male
anim
time
point
h
one
anim
kill
blood
lymph
node
lung
spleen
brain
kidney
gonad
heart
liver
harvest
care
control
condit
prevent
crosscontamin
vector
differ
organ
organ
either
snap
frozen
store
individu
vial
qpcr
analysi
gener
confid
interv
minimum
three
replic
well
requir
prefer
ensur
result
express
posit
neg
confid
use
duplic
singl
well
control
allow
comparison
group
carri
accur
due
signific
high
valu
tstatist
use
one
degre
freedom
howev
work
limit
budget
perform
studi
use
duplic
reaction
replic
allow
data
express
mean
copi
number
within
specifi
standard
deviat
use
duplic
well
mean
standard
deviat
allow
gener
confid
interv
howev
use
singl
well
give
inform
welltowel
reproduc
use
research
purpos
rather
biosafeti
test
confid
result
essenti
produc
accur
set
data
cover
dynam
rang
assay
standard
curv
minimum
four
five
standard
includ
minimum
four
five
differ
dilut
case
achiev
assess
c
valu
rang
assay
everi
pcr
run
control
essenti
sinc
anim
dose
gene
therapi
vector
like
contain
pcrposit
tissu
sentinel
extract
includ
handl
posit
sampl
control
level
crosscontamin
sampl
extract
import
sentinel
extract
highlight
sinc
qpcr
reaction
sentinel
neg
extract
sentinel
posit
control
ensur
recoveri
test
anim
nucleic
acid
necessari
sinc
valid
extract
procedur
perform
anoth
time
point
actual
test
sampl
assay
control
replac
preextract
spike
recoveri
control
mention
target
integr
cellular
dna
integr
vector
dna
host
genom
assess
preextract
postextract
spike
control
quantifi
percent
recoveri
extract
inhibit
pcr
perform
even
prestudi
nucleic
acid
extract
valid
alreadi
give
inform
test
sampl
biodistribut
assay
perform
time
point
prestudi
possibl
variabl
time
point
exampl
variat
solut
batch
differ
oper
error
problem
extract
reagent
spike
recoveri
control
perform
time
test
ensur
potenti
problem
detect
ipc
also
known
taqman
exogen
intern
posit
control
reagent
includ
qpcr
master
mix
control
replac
postextract
spike
control
sinc
pcr
inhibit
detect
ipc
reagent
ipc
set
primer
probe
target
nonbiolog
synthet
templat
multiplex
pcr
reaction
ipc
detect
use
viclabel
probe
viralrcel
target
nucleic
acid
detect
use
famlabel
probe
ipc
reagent
spike
reaction
distinguish
true
target
neg
pcr
inhibit
addit
data
gener
pcrneg
well
presenc
ipc
ensur
truli
neg
viral
target
due
fail
amplif
therebi
give
extra
confid
result
addit
viral
detect
quantif
qpcr
wide
use
detect
chang
gene
copi
number
mrna
express
plasmid
dna
level
qpcr
combin
dna
sequenc
restrict
map
commonli
use
genet
stabil
test
exampl
common
use
qpcr
research
velop
qualiti
control
includ
detec
tion
chang
plasmid
dna
copi
number
e
coli
yeast
cell
bank
develop
project
larg
scale
product
detect
chang
transgen
copi
number
malintegr
express
cassett
yeast
mammalian
cell
bank
copi
number
gene
mrna
level
assess
express
chang
gene
express
respons
therapeut
product
recent
approach
vaccin
involv
direct
introduct
recombin
plasmid
dna
gene
therapi
vector
appropri
tissu
ro
bertson
griffith
mahato
et
al
includ
administr
plasmid
dna
complex
cation
lipid
treatment
genet
acquir
diseas
gao
haung
sinc
plasmid
receiv
increas
attent
use
vector
gene
therapi
prepar
method
monitor
stabil
yield
fundament
import
manufactur
monitor
chang
transgen
copi
number
level
mrna
express
critic
isol
stabl
cell
line
streamlin
construct
product
howev
product
purif
larg
amount
therapeut
plasmid
vector
hinder
number
factor
includ
bacteri
host
strain
plasmid
dna
instabl
copi
number
per
cell
togeth
restrict
endonucleas
map
nucleotid
sequenc
analysi
phenotyp
test
routin
monitor
plasmid
copi
number
utmost
import
larg
scale
cultur
genet
instabl
caus
signific
problem
smith
et
al
convent
procedur
determin
plasmid
dna
copi
number
labori
requir
dna
extract
restrict
endonucleas
digest
agaros
electrophoresei
ethidium
bromid
stain
therefor
high
throughput
method
calcul
copi
number
plasmid
vector
construct
ferment
paramount
obtain
maximum
effici
downstream
process
use
qpcr
assay
target
region
plasmid
origin
replic
antibiot
resist
gene
human
cmv
promot
therapeut
transgen
possibl
identifi
specif
chang
plasmid
copi
number
differ
microbi
construct
assess
relationship
cell
number
c
valu
linear
demonstr
allow
direct
determin
plasmid
dna
copi
number
cultur
sampl
rel
refer
plasmid
contain
e
coli
strain
fourfold
differ
plasmid
dna
copi
number
detect
therefor
procedur
use
monitor
microbi
ferment
optimis
product
method
tabl
two
method
quantifi
target
molecul
realtim
qpcr
term
rel
absolut
quantif
rel
quantif
use
endogen
control
normalis
amount
plasmid
molecul
sampl
normalis
valu
assess
signific
increas
decreas
copi
number
plasmid
dna
independ
convent
measur
cell
number
incorpor
rel
quantif
could
provid
potenti
screen
coloni
volum
cultur
di
fourfold
differ
cell
number
detect
confid
interv
data
show
statist
differ
rectli
rel
quantif
calcul
numer
differ
endogen
chromosom
gene
number
plasmid
molecul
microbi
sampl
way
signific
differ
plasmid
target
endogen
control
detect
provid
inform
plasmid
dna
molecul
per
cell
use
approach
assay
could
independ
od
standardis
still
abl
detect
twoto
fourfold
differ
copi
number
taken
togeth
qpcr
sever
implic
monitor
genet
stabil
plasmid
dna
microbi
construct
select
product
qpcr
use
measur
copi
number
wide
rang
differ
cell
number
genom
equival
abl
assess
copi
number
stabil
master
cell
bank
mcb
work
cell
bank
wcb
post
product
cell
bank
pcb
signific
chang
demonstr
perform
statist
analysi
c
valu
obtain
mcb
wcb
pcb
copi
number
cell
bank
express
confid
interv
numer
c
valu
confid
interv
cell
bank
overlap
demonstr
data
deriv
stage
manufactur
process
deriv
statist
popul
statist
data
ps
level
provid
mean
monitor
signific
chang
copi
number
manufactur
process
qpcr
accur
southern
blot
techniqu
detect
alter
gene
copi
number
sinc
estim
southern
blot
reli
comparison
band
intens
autoradiograph
southern
blot
analysi
gener
use
inform
structur
integr
integr
construct
provid
approxim
evalu
copi
number
term
stabil
increas
copi
number
transgen
cell
line
occur
chromosom
duplic
signific
increas
copi
number
detect
manufactur
process
fluoresc
situ
hybridis
fish
analysi
perform
investig
stabil
construct
direct
chromosom
duplic
associ
structur
alter
would
miss
southern
analysi
integr
express
cassett
remain
unalt
duplic
structur
analysi
detect
chang
express
cassett
caus
delet
insert
recombinationrdupl
integr
construct
anoth
chromosom
locat
therefor
rapid
screen
qpcr
assay
aid
detect
chromosom
duplic
result
increas
copi
number
associ
structur
alter
detect
southern
blot
analysi
increas
rate
discoveri
previous
unrecognis
virus
safeti
becom
utmost
concern
biotechnolog
manufactur
addit
addit
pressur
fast
assay
develop
optimis
valid
test
method
valid
test
avail
qpcr
begin
revolutionis
product
batch
releas
product
high
versatil
qpcr
assay
coupl
high
reproduc
fast
throughput
abil
doubt
assist
decreas
time
develop
safeti
test
final
market
novel
biotechnolog
product
carri
develop
program
significantli
contribut
toward
solv
problem
encount
